Latest Breaking News On - பாரத் பயோடெக் சர்வதேச வரையறுக்கப்பட்டவை - Page 19 : comparemela.com
Bharat Biotech submitted 90 pc of documentation to WHO for emergency use listing for Covaxin: Sources
yourstory.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yourstory.com Daily Mail and Mail on Sunday newspapers.
Bharat Biotech awaits emergency use approval from WHO for COVID-19 vaccine
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Coronavirus live updates | Government reviews process to get WHO approval for Covaxin vaccine
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
WHO says ‘more information’ required from Bharat Biotech for emergency use listing of Covaxin
Updated:
Updated:
A pre-submission meeting is expected “to be planned May-June 2021,” the guidance document said.
Share Article
AAA
A health worker displays vials of Covaxin at a vaccination centre in Jammu. File
| Photo Credit:
AP
A pre-submission meeting is expected “to be planned May-June 2021,” the guidance document said.
The World Health Organisation (WHO) said “more information” is “required” from Bharat Biotech, which is seeking emergency use listing (EUL) for its Covaxin vaccine for COVID-19.
The latest ‘Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process’ guidance document dated May 18 on the WHO website said Bharat Biotech submitted EOI (Expression of Interest) on April 19 and that “More information required”. A pre-submission meeting is expected “to be planned May-June 2021,” the guidance document said.
Bharat Biotech International Limited (BBIL) has conveyed to the government that it has already submitted 90 per cent of documents to WHO for obtaining emergency use listing (EUL) for the Covaxin vaccine, sources said on Monday. The remaining documents are expected to be submitted by June, the Hyderabad-based Bharat Biotech Ltd told the Central government during a discussion on obtaining the World Health Organisation s authorisation for emergency use listing for Covaxin, sources said. BBIL is confident about obtaining WHO s emergency use listing, said a source. Sources also said that no country has instituted a vaccine passport and that countries around the world have their own requirements for approval which, in most cases, involves travel by carrying a COVID-19 negative RT-PCR report.